Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.
Related Posts
Alibaba, Nio Mixed: Hang Seng Trades Flat As Inflation Data Eyed, China COVID-19 Lockdowns Weigh
Hong Kong shares were trading flat on Friday, with the benchmark Hang Seng edging just 0.05% up, ahead of the release of the inflation report in the city. Shares of Alibaba rose 0.72% in morning trade, while Xpeng shares gained over 5%.
Aurora Mobile Signed Strategic Agreement with BYD Company for Its Overseas Messaging Cloud Solution
Aurora Mobile Limited (NASDAQ: JG) today announced that it has signed a strategic agreement with BYD Company Limited (002594.SZ) ("BYD") to help the automobile manufacturer expand its new energy vehicle business in Europe using its overseas messaging cloud solution (the "Solution").
Revving Up for Summer: Six Flags’ Financial Loop-The-Loop, But CEO Promises Thrilling Comeback
Six Flags Entertainment faces challenges with a 6.3% sales dip in Q1 FY24, totaling $133.291 million, attributed to a $12 million fall in membership revenue post-commitment period, while attendance sees a 6% rise to 1.7 million guests. Despite a per capita spending drop to $74.35, CEO Selim Bassoul emphasizes commitment to enhancing guest experiences with upcoming summer attractions.